Myocardial infarction in users of low-dose oral contraceptives

Obstetrics and Gynecology

Volumn 88, Issue 6, 1996, Pages 939-944

  Sidney, Stephen ^a   Petitti, Diana B ^b   Quesenberry Jr , Charles P ^b   Klatsky, Arthur L ^b   Ziel, Harry K ^b   Wolf, Sheldon ^b  

^a DIVISION OF RESEARCH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ORAL CONTRACEPTIVE AGENT;

ACUTE HEART INFARCTION; ADOLESCENT; ADULT; AGE; ARTICLE; BODY MASS; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFECT; DRUG SAFETY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0030560764     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(96)00351-1     Document Type: Article

References (26)

1. 1. Inman WHW, Vessey MP. Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age. BMJ 1968;2:193-9.
2. 2. Vessey MP, Doll R. Investigation of relation between use of oral contraceptives and thromboembolic disease: A further report. BMJ 1969;2:651-7.
3. 3. Mann JI, Vessey MP, Thorogood M, Doll R. Myocardial infarction in young women with special reference to oral contraceptive practice. BMJ 1975;2:241-5.
4. 4. Mann JI, Inman WHW. Oral contraceptives and death from myocardial infarction. BMJ 1975;2:245-8.
5. 5. Jick H, Dinan B, Rothman KJ. Oral contraceptives and nonfatal myocardial infarction. JAMA 1978;239:1403-6.
6. 6. Rosenberg L, Hennekens CH, Rosner B, Belanger C, Rothman KJ, Speizer FE. Oral contraceptive use in relation to nonfatal myocardial infarction. Am J Epidemiol 1980;111:59-66.
7. 7. Slone D, Shapiro S, Kaufman DW, Rosenberg L, Miettinen OS, Stolley PD. Risk of myocardial infarction in relation to current and discontinued use of oral contraceptives. N Engl J Med 1981;305: 420-4.
8. 8. Adam SA, Thorogood M, Mann JI. Oral contraception and myocardial infarction revisited: The effects of new preparations and prescribing patterns. Br J Obstet Gynaecol 1981;88:838-45.
9. 9. Maguire MG, Tonascia J, Sartwell PE, Stolley PD, Tockman MS. Increased risk of thrombosis due to oral contraceptives: A further report. Am J Epidemiol 1979;110:188-95.
10. 10. Krueger De, Ellenberg SS, Bloom S, Calkins BM, Maliza C, Nolan DC. Fatal myocardial infarction and the role of oral contraceptives. Am J Epidemiol 1980;111:655-74.
11. 11. Rosenberg L, Palmer JR, Lesko SM, Shapiro S. Oral contraceptive use and the risk of myocardial infarction. Am J Epidemiol 1990; 131:1009-16.
12. 12. Croft P, Hannaford PC. Risk factors for acute myocardial infarction in women: Evidence from the Royal College of General Practitioners′ oral contraception study. BMJ 1989;298:165-8.
13. 13. Thorogood M, Mann J, Murphy M, Vessey M. Is oral contraceptive use still associated with an increased risk of fatal myocardial infarction? Br J Obstet Gynaecol 1991;98:1245-53.
14. 14. D'Avanzo B, La Vecchia C, Negri E, Parazzini F, Franceschi S. Oral contraceptive use and risk of myocardial infarction: An Italian case-control study. J Epidemiol Community Health 1994;48:324-5.
15. 15. Petitti DB, Sidney S, Bernstein A, Wolf S, Quesenberry CP, Ziel HK. Stroke in users of low dose oral contraceptives. N Engl J Med 1996;335:8-15.
16. 16. Gillum RF, Fortmann S, Prineas RJ, Kottke TE. International diagnostic criteria for myocardial infarction and acute stroke. (Prepared for the Committee on Criteria and Methods, Council on Epidemiology, American Heart Association). Am Heart J 1984;108: 150-8.
17. 17. Gillum RF. Cardiovascular disease in the United States: An epidemiologic overview. In: Saunders E, Brest AN, eds. Cardiovascular diseases in blacks. Philadelphia: FA Davis, 1991:3-16.
18. 18. Rothman KJ. Modern epidemiology. Boston, Massachusetts: Little Brown & Co, 1986:38-9.
19. 19. Stampfer MJ, Willett WC, Colditz GA, Speizer FE, Hennekens CH. A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases. N Engl J Med 1988;319:1313-7.
20. 20. Stadel BV. Oral contraceptives and cardiovascular disease. N Eng J Med 1981;305:612-8, 672-7.
21. 21. Hiatt RA, Friedman GD. The frequency of kidney and urinary tract diseases in a defined population. Kidney Int 1982;22:63-8.
22. 22. Krieger N. Overcoming the absence of socioeconomic data in medical records. Am J Public Health 1992;82:703-10.
23. 23. Meade TW, Greenberg F, Thompson SG. Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram estrogen preparations. BMJ 1980;280:1157-61.
24. 24. Kay CR. Progestogens and arterial disease: Evidence from the Royal College of General Practitioners′ study. Am J Obstet Gynecol 1982;142:762-5.
25. 25. Bradley D, Wingerd J, Petitti DB, Krauss R, Ramcharan S. Serum high-density lipoprotein cholesterol in women using oral contraceptives, estrogens, and progestins. N Engl J Med 1978;299:17-20.
26. 26. Ory HW, Forrest JD, Lincoln R. Making choices: Evaluating the health risks and benefits of birth control methods. New York: Alan Guttmacher Institute, 1983.